SG Americas Securities
VAXX

SG Americas Securities’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

SG Americas Securities’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,140
Closed -$14K – 3525
2023
Q3 		$14K Buy
+10,140
New +$22K ﹤0.01% 3058

Other funds holding VAXX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

SG Americas Securities's VAXX Position: Q4 2023 in Review

SG Americas Securities sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q4 2023, closing a stake of 10,140 shares — an estimated $14K sold.

SG Americas Securities first reported a position in VAXX in Q3 2023 and held it in 1 quarter. The position peaked at $14K in Q3 2023. 59 funds tracked by Wall St. Rank hold VAXX as of Q4 2023.

  • SG Americas Securities reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q4 2023 after selling out during the quarter.
  • SG Americas Securities sold 10,140 Vaxxinity, Inc. Class A Common Stock shares in Q4 2023, an estimated $14K.
  • SG Americas Securities first reported a position in Vaxxinity, Inc. Class A Common Stock in Q3 2023 and held it in 1 quarter.
  • SG Americas Securities's Vaxxinity, Inc. Class A Common Stock position peaked at $14K in Q3 2023.
  • 59 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q4 2023.

Based on SG Americas Securities's 13F filing for Q4 2023, filed 12 Jan 2024.